GLOW 70MG

GLOW - Multi-Pathway Regenerative Research in One Vial

The GLOW 70MG Peptide Blend from Helio Peptides is a triple-peptide research formulation combining three of the most extensively studied regenerative peptides in the published preclinical literature: GHK-Cu (Copper Tripeptide-1) at 50MG, BPC-157 (Body Protection Compound-157) at 10MG, and TB-500 (Thymosin Beta-4 fragment) at 10MG - in a single lyophilised vial formulated for multi-target regenerative research. Each component targets a distinct biological mechanism: GHK-Cu drives collagen synthesis and extracellular matrix remodelling through copper-dependent enzymatic pathways; BPC-157 promotes tissue repair and GI mucosal protection through nitric oxide and growth factor signalling; TB-500 regulates cell migration, angiogenesis, and actin polymerisation through thymosin beta-4 pathway modulation. Together, the three compounds provide a comprehensive research tool for studying complementary regenerative mechanisms in a single experimental design.

Helio Peptides operates differently.

Every vial of GLOW is tested by an ISO 17025-accredited third-party laboratory before it ships - identity and purity confirmed by HPLC and mass spectrometry for each blend component, and assay content verified at the labelled 70MG total. At $89.95 per vial - or $80.96 in a pack of ten - GLOW provides one of the most cost-efficient formats for multi-pathway regenerative research available from a US-based, ISO-accredited tested supplier. Individual vials of each component are also available separately: GHK-Cu 50MG Vial, BPC-157 Vial, and TB-500 5MG Vial - for studies requiring individual component characterisation.

What Is the GLOW Peptide Blend?

The GLOW 70MG Peptide Blend is a research formulation combining three distinct peptides - GHK-Cu, BPC-157, and TB-500 - in a single lyophilised vial. Each compound has an independent, well-characterised research profile; the GLOW blend is designed for studies examining how their complementary mechanisms interact and whether multi-peptide combined use produces additive or synergistic outcomes in regenerative, dermatological, and tissue repair model systems.

The name 'GLOW' reflects the primary research focus areas of the blend - skin matrix remodelling, collagen synthesis, angiogenesis, and tissue repair - and is a colloquial research label used across the peptide research community to describe GHK-Cu/BPC-157/TB-500 combination vials.

The three components are available as individual research vials for single-compound work: GHK-Cu 50MG Vial for isolated copper peptide research; BPC-157 Vial for isolated body protection compound research; and TB-500 5MG Vial for isolated thymosin beta-4 fragment research. The GLOW blend is the appropriate format when the research objective is to study the combined three-component profile rather than isolate individual mechanisms.

What Each Component Does - The Science Behind the Blend

GHK-Cu (Copper Tripeptide-1) - 50MG | Collagen and Matrix Remodelling

GHK-Cu (glycyl-L-histidyl-L-lysine-copper complex) is a naturally occurring copper-binding tripeptide found in human plasma, saliva, and urine. It is one of the most extensively studied cosmetic and dermatological research peptides in the published literature, with documented effects on collagen and elastin synthesis, matrix metalloproteinase (MMP) regulation, wound healing, anti-inflammatory signalling, and antioxidant defence across multiple in vitro and in vivo model systems. GHK-Cu stimulates fibroblast collagen synthesis through copper-dependent lysyl oxidase activation and upregulation of collagen I and III gene expression. It simultaneously regulates MMPs in a remodelling context - promoting collagen synthesis while modulating MMP activity to facilitate organised matrix turnover rather than uncontrolled degradation.

At 50MG in the GLOW blend - the largest component by mass - GHK-Cu represents the primary regenerative scaffold-building component. Research applications include skin fibroblast collagen synthesis assays, wound closure rate studies in cell scratch assays, MMP activity characterisation, and dermal matrix remodelling in ex vivo skin models. Individual vials: GHK-Cu 50MG Vial.

BPC-157 (Body Protection Compound-157) - 10MG | Systemic Repair and Cytoprotection

BPC-157 is a synthetic 15-amino acid peptide derived from a sequence within the human gastric juice protein Body Protection Compound. It is one of the most studied regenerative research peptides across the published preclinical literature, with documented effects on tendon and ligament repair, gastrointestinal mucosal protection, nitric oxide signalling, angiogenesis, and systemic cytoprotection across rodent model systems. BPC-157's mechanism involves upregulation of VEGF (vascular endothelial growth factor), FAK/paxillin pathway activation for accelerated fibroblast and tenocyte migration, and direct modulation of the NO-cGMP pathway in vascular tissue.

In the GLOW blend, BPC-157 contributes the vascular and systemic repair component - promoting angiogenesis and blood vessel formation in regenerating tissue alongside GHK-Cu's matrix synthesis and TB-500's cell migration effects. Individual vials: BPC-157 Vial.

TB-500 (Thymosin Beta-4 Fragment) - 10MG | Cell Migration and Angiogenesis

TB-500 is a synthetic fragment of Thymosin Beta-4 - specifically the actin-binding domain (residues 17–23) of the full 43-amino acid thymic peptide. It is studied for its role in actin polymerisation regulation, cell migration, angiogenesis, anti-inflammatory signalling, and tissue regeneration across muscle, cardiac, corneal, dermal, and neural model systems. TB-500 promotes cell migration by sequestering G-actin and modulating the dynamic actin cytoskeleton, allowing cells to migrate faster into wound sites. It simultaneously promotes new blood vessel formation through upregulation of VEGF and HIF-1α in hypoxic tissue environments.

In the GLOW blend, TB-500 adds the cell mobility and angiogenic component - enabling coordinated cellular infiltration of repair sites alongside GHK-Cu's matrix synthesis and BPC-157's vascular and cytoprotective effects. Individual vials: TB-500 5MG Vial.

Why These Three Together? The Synergy Rationale

The three components of the GLOW blend target complementary, non-redundant mechanisms in the tissue repair cascade:

• GHK-Cu - provides the structural framework: stimulates collagen and elastin synthesis, regulates ECM turnover via MMPs, and creates the scaffold into which repairing tissue grows

• TB-500 - provides the cellular mobility: regulates actin dynamics for faster cell migration, and promotes angiogenesis to establish vascular supply to the repair site

• BPC-157 - provides the vascular and protective component: promotes VEGF-driven angiogenesis, activates FAK/paxillin for fibroblast mobilisation, and protects cells from ischaemic and oxidative damage during repair

Research designs examining synergy compare GLOW (combined) against matched individual compound controls at the same total molar concentration - identifying whether the combined effect at each endpoint exceeds the sum of individual effects, or whether specific pathway interactions produce antagonism at particular concentration ratios.

Research Applications

The GLOW 70MG blend is investigated across regenerative biology, dermatology, wound healing, and vascular research contexts. All applications below are for controlled laboratory environments only. This product is for research use only and is not for human or animal consumption.

Skin Biology and Dermal Matrix Research

The primary application for the GLOW blend is dermal matrix remodelling and skin regeneration research. The three-component profile maps precisely onto the key cellular processes involved in skin repair: GHK-Cu for fibroblast collagen synthesis and ECM organisation; BPC-157 for dermal angiogenesis and fibroblast migration via FAK activation; TB-500 for actin-mediated keratinocyte and fibroblast motility. Research applications include collagen synthesis assays in primary human fibroblast cultures, scratch wound closure assays, MMP activity characterisation, ex vivo skin punch wound models, and comparison against single-component controls to characterise synergistic versus additive effects at each endpoint.

Wound Healing and Tissue Repair Research

The GLOW blend is used in wound healing model systems including in vitro scratch assays, murine excisional wound models, and ex vivo wound biopsy assays. The combination of angiogenic (BPC-157, TB-500), proliferative (GHK-Cu via TGF-β and FGF upregulation), and migratory (TB-500 via actin regulation) mechanisms across the three components provides a comprehensive toolkit for studying the wound healing cascade from vascular ingrowth through matrix deposition to tissue maturation. Research designs commonly compare GLOW against individual components and against the BPC-157 + TB-500 pairing alone (available as the BPC-157 + TB-500 Peptide Bundle) to characterise the marginal contribution of GHK-Cu.

Angiogenesis and Vascular Remodelling Research

Both BPC-157 and TB-500 have documented pro-angiogenic activity in published preclinical research - through VEGF upregulation and direct endothelial cell migration promotion respectively. The GLOW blend provides a dual-angiogenic plus matrix-remodelling research system for studying coordinated vascular and connective tissue repair in hypoxia, ischaemia-reperfusion, and wound healing models. Research endpoints include tube formation assays in HUVECs (human umbilical vein endothelial cells), VEGF and HIF-1α expression by qPCR/Western blot, and in vivo Matrigel plug angiogenesis assays.

Anti-Inflammatory and Cytoprotection Research

All three components of the GLOW blend have documented anti-inflammatory properties in published preclinical literature: GHK-Cu through downregulation of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) and NF-κB pathway modulation; BPC-157 through NO-cGMP pathway activation and systemic cytoprotection in ischaemia models; TB-500 through thymosin beta-4 pathway-mediated reduction of inflammatory mediator production in cardiac and dermal tissue models. The combined anti-inflammatory profile makes GLOW relevant to research examining multi-pathway inflammatory suppression in tissue repair contexts.

Comparative Single vs Combination Peptide Research

One of the most scientifically valuable applications of the GLOW blend is its use as the combination arm in systematic single-versus-combination experimental designs. Running GLOW against matched individual controls of GHK-Cu, BPC-157, and TB-500 at equivalent molar amounts allows rigorous characterisation of whether the combination produces additive, synergistic, or antagonistic effects at each research endpoint. This design is increasingly recognised as the appropriate methodology for multi-peptide blend research, enabling quantitative synergy analysis using Bliss independence or Loewe additivity models.

Product Specifications

Purity Testing & Certificate of Analysis

Every batch of Helio Peptides GLOW blend is independently tested before release. Not sampled - every batch. Testing is conducted by an ISO 17025-accredited third-party laboratory:

• HPLC (High-Performance Liquid Chromatography): Confirms identity and purity of each blend component (GHK-Cu, BPC-157, TB-500) at ≥99% - detects synthesis by-products and verifies blend stoichiometry

• Mass Spectrometry (MS): Confirms molecular mass of each component - rules out synthesis artefacts for all three peptides in the blend

• Assay / Content Testing: Confirms total peptide content per vial matches the labelled 70MG and verifies the individual component ratio (GHK-Cu 50MG : BPC-157 10MG : TB-500 10MG)

COA available on request. Email info@heliopeptides.com. For testing methodology, visit our Certificate of Analysis and Testing page. Handling guidance on our FAQ page.

Storage Guidelines

• On delivery: refrigerate or freeze immediately

• Short-term (days to weeks): refrigerate at 4°C, away from direct light, in original sealed vial

• Long-term (months to years): freeze at -20°C to -80°C - optimal for extended stability of all three blend components

• Avoid repeated freeze-thaw cycles: aliquot into single-use volumes before freezing

Helio Peptides ships all vials with cold-chain packaging. Contact info@heliopeptides.com or call 1-855-435-4633 immediately if you have concerns on arrival.

Pack Options

For research requiring individual component isolation, each peptide is available separately. For programmes combining GLOW with additional regenerative compounds, explore our Peptide Bundles and Stacks page. For institutional or wholesale pricing, contact our wholesale team.

How GLOW Fits the Helio Peptide Lineup

When to choose GLOW blend: Your research objective is studying the combined regenerative profile of GHK-Cu, BPC-157, and TB-500 in a single experimental design - either characterising synergistic interactions or running efficient multi-endpoint regenerative model studies where single-vial exposure simplifies study design.

When to use individual components instead: When your research requires isolation of a specific mechanism - copper-dependent collagen synthesis (GHK-Cu Vial) - nitric oxide and GI repair mechanisms (BPC-157 Vial) - or actin regulation and angiogenesis (TB-500 5MG Vial). Individual vials also allow concentration flexibility - independent concentration adjustments impossible with a fixed-ratio blend.

When to also consider Thymosin Alpha 1: For multi-peptide research programmes combining regenerative and immune biology, our Thymosin Alpha 1 5MG Vial covers TLR pathway modulation and T-cell differentiation - relevant to the immune-mediated components of wound healing and tissue repair research.

When to also consider KPV: For regenerative programmes with a focus on anti-inflammatory mechanisms, our KPV 10MG Vial is the α-MSH tripeptide with documented anti-inflammatory and gut-mucosal repair properties - complementary to GLOW's repair-focused profile.

When to also consider Glutathione: For research examining oxidative stress alongside tissue repair, our Glutathione 1500MG Vial covers cellular redox biology and antioxidant defence mechanisms that support the regenerative environment studied with GLOW.

When to also consider GHK-Cu + KPV blend: Researchers studying anti-inflammatory skin biology alongside collagen synthesis may also consider our GHK-Cu + KPV Peptide Bundle as a complementary formulation targeting both matrix remodelling and inflammatory suppression.

Shipping & Fulfilment

Frequently Asked Questions

What is GLOW peptide blend?

GLOW 70MG is a triple-peptide research blend from Helio Peptides combining GHK-Cu (Copper Tripeptide-1, 50MG), BPC-157 (Body Protection Compound-157, 10MG), and TB-500 (Thymosin Beta-4 fragment, 10MG) in a single lyophilised vial. It is formulated for multi-pathway regenerative research examining collagen synthesis (GHK-Cu), tissue repair and angiogenesis (BPC-157), and cell migration (TB-500) simultaneously. Research use only - not for human or animal consumption.

What peptides are in GLOW 70MG?

GLOW 70MG contains three peptides: GHK-Cu (Copper Tripeptide-1) at 50MG (71.4% of the blend), BPC-157 (Body Protection Compound-157) at 10MG (14.3%), and TB-500 (Thymosin Beta-4 fragment) at 10MG (14.3%). Total blend content: 70MG per vial.

What is GHK-Cu and what does it do in research?

GHK-Cu (glycyl-L-histidyl-L-lysine-copper complex) is a copper-binding tripeptide naturally present in human plasma. In research settings it stimulates collagen I and III synthesis in fibroblasts, regulates matrix metalloproteinase activity for organised ECM turnover, promotes wound healing, and exerts anti-inflammatory effects through NF-κB pathway modulation. It is the dominant component of the GLOW blend at 50MG per vial. Available separately as GHK-Cu 50MG Vial.

What is BPC-157 and what does it do in research?

BPC-157 (Body Protection Compound-157) is a synthetic 15-amino acid pentadecapeptide derived from human gastric juice protein. Research applications include tendon and ligament repair, gastrointestinal mucosal protection, VEGF-driven angiogenesis, FAK/paxillin pathway activation, and NO-cGMP signalling in vascular tissue. Available separately as BPC-157 Vial.

What is TB-500 and what does it do in research?

TB-500 (Thymosin Beta-4 fragment) is the actin-binding domain fragment (residues 17–23) of Thymosin Beta-4. Research applications include actin polymerisation regulation for enhanced cell migration, VEGF-driven angiogenesis in hypoxic tissue, anti-inflammatory thymosin beta-4 pathway modulation, and tissue repair in cardiac, corneal, dermal, and neural models. Available separately as TB-500 5MG Vial.

Why combine GHK-Cu, BPC-157, and TB-500 in one blend?

The three components target complementary, non-redundant mechanisms in tissue repair: GHK-Cu provides the collagen synthesis and ECM remodelling substrate; TB-500 provides actin-mediated cell migration and angiogenic signalling; BPC-157 provides vascular repair, FAK-driven fibroblast mobilisation, and cytoprotection. Together they cover the structural, cellular, and vascular components of the repair cascade. Research designs use the combined GLOW blend as the experimental arm against individual component controls to characterise additive or synergistic interactions.

Is every batch of GLOW third-party tested?

Yes - every batch. ISO 17025-accredited laboratory testing confirms identity, purity (≥99% per component), blend stoichiometry, and total content at 70MG. Visit our Certificate of Analysis page or email info@heliopeptides.com to request your batch COA.

Can I buy GHK-Cu, BPC-157, and TB-500 individually?

Yes. Individual vials are available: GHK-Cu 50MG Vial, BPC-157 Vial, and TB-500 5MG Vial. Individual vials are appropriate when your research requires single-compound isolation. The GLOW blend is appropriate when multi-component combination research is the objective.

Where is Helio Peptides GLOW manufactured?

Synthesised in the United States in a controlled US-based facility. USA made, USA tested, shipped same day with cold-chain packaging.

Does Helio Peptides ship internationally?

Contact info@heliopeptides.com or call 1-855-435-4633 for current international shipping availability. Domestic US orders: same-day dispatch, 1–3 business day delivery.

What payment methods are accepted?

Credit/debit card (3D Secure), bank transfer, Ethereum (ETH), Bitcoin (BTC), and USDC at locked exchange rates.

Is there a bulk discount on GLOW?

Yes. Pack of 10 at $80.96 per vial - 10% saving over $89.95 single price, $809.60 total. For institutional or wholesale quantities, contact our wholesale team.

Is GLOW legal to buy in the USA?

GLOW 70MG (GHK-Cu + BPC-157 + TB-500 blend) is sold as a research chemical for laboratory use only. None of the three components are scheduled controlled substances in the United States. All purchases must comply with applicable federal and state laws. Buyers confirm research intent at checkout. Not for human consumption.

Explore More From Helio Peptides

• GHK-Cu 50MG Vial - copper tripeptide, collagen synthesis and skin matrix remodelling research

• BPC-157 Vial - tissue repair, GI mucosal protection, angiogenesis research

• TB-500 5MG Vial - thymosin beta-4 fragment, cell migration and tissue regeneration research

• KPV 10MG Vial - anti-inflammatory α-MSH tripeptide, gut and skin inflammatory research

• Thymosin Alpha 1 5MG Vial - immune modulation and wound healing immune-biology research

• Glutathione 1500MG Vial - redox biology, antioxidant defence, skin and tissue oxidative stress research

• Snap-8 (Acetyl Octapeptide-3) 10MG Vial - SNARE-targeting cosmetic peptide, expression-line and neuromuscular research

• Epithalon 10MG Vial - longevity and bioregulator research

• Peptide Bundles & Stacks - curated multi-peptide research combinations

• Certificate of Analysis & Testing - ISO 17025 testing methodology

• Wholesale & Bulk Orders - institutional pricing for research programmes

All products sold on heliopeptides.com are intended solely for laboratory research and are not for human or animal consumption. These statements have not been evaluated by the Food and Drug exposure. These products are not intended to diagnose, treat, cure, or prevent any disease. Helio Peptides does not condone or support the use of peptides outside of controlled scientific research. By purchasing, the buyer confirms they are a qualified researcher or institution aged 21 or older, and agrees to comply with all applicable federal and state laws.